Show simple item record

dc.contributor.authorWilliams, MHen_NZ
dc.contributor.authorCairns, SPen_NZ
dc.contributor.authorSimmons, Den_NZ
dc.contributor.authorRush, ECen_NZ
dc.date.accessioned2018-01-10T02:27:43Z
dc.date.available2018-01-10T02:27:43Z
dc.date.copyright2017en_NZ
dc.identifier.citationThe New Zealand medical journal, 130(1465), 71-79.
dc.identifier.issn0028-8446en_NZ
dc.identifier.urihttp://hdl.handle.net/10292/11063
dc.description.abstractAim In Aotearoa/New Zealand, the proportion of Māori who participate in the national Green Prescription lifestyle programme is lower than for New Zealand Europeans. We compared the uptake and effectiveness of two modes of Green Prescription delivery: face-to-face and telephone among both Māori and New Zealand Europeans. Method Sixty-eight Māori and 70 New Zealand Europeans with type-2 diabetes participated in this six-month randomised trial of the two modes of delivery. Recruitment integrated an explicitly Māori culturally sensitive approach. All participants received lifestyle intervention. Anthropometry, blood lipids and glycated haemoglobin were measured before and after the intervention. Results The face-to-face approach (first meeting) yielded 100% uptake into the programme among both Māori and New Zealand Europeans. At six months there were overall reductions in weight (1.8; [95 CI%, 0.6, 2.9kg]), waist circumference (3.7 [2.6, 4.8cm]), and total cholesterol (0.6 [0.3, 0.9mmol/l]) and glycated haemoglobin (3.1 [-0.2, 6.7mmol/mol]). There were no significant differences by mode of delivery, ethnicity or gender. Conclusion The Green Prescription programme resulted in small but clinically favourable improvements in health outcomes for type-2 diabetes patients, regardless of the mode of delivery for both Māori and New Zealand Europeans.
dc.publisherNew Zealand Medical Associationen_NZ
dc.relation.urihttp://www.nzma.org.nz/journal/read-the-journal/all-issues/2010-2019/2017/vol-130-no-1465-10-november-2017/7410
dc.titleFace-to-face Versus Telephone Delivery of the Green Prescription for Maori and New Zealand Europeans With Type-2 Diabetes Mellitus: Influence on Participation and Health Outcomesen_NZ
dc.typeJournal Article
dc.rights.accessrightsOpenAccessen_NZ
pubs.elements-id215176
aut.relation.journalNew Zealand Medical Journalen_NZ


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record